Literature DB >> 347855

Serum lipids and lipoproteins during treatment with oral contraceptives containing natural and synthetic oestrogens. A controlled double-blind investigation.

E Bostofte, L Hemmingsen, K J Møller, J Serup, T Weber.   

Abstract

Entities:  

Keywords:  Age Factors; Biology; Contraception; Contraceptive Agents, Estrogen--side effects; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--administraction and dosage; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--administraction and dosage; Contraceptive Agents--side effects; Contraceptive Methods--side effects; Double-blind Studies; Endocrine System; Estradiol--administraction and dosage; Estradiol--side effects; Estriol--administraction and dosage; Estriol--side effects; Estrogens--side effects; Family Planning; Hematological Effects; Hemic System; Hormones; Lipid Metabolic Effects; Lipids; Norethindrone Acetate--administraction and dosage; Norethindrone Acetate--side effects; Norethindrone--administraction and dosage; Norethindrone--side effects; Oral Contraceptives, Combined; Oral Contraceptives--side effects; Physiology; Research Methodology; Studies

Mesh:

Substances:

Year:  1978        PMID: 347855     DOI: 10.1530/acta.0.0870855

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


× No keyword cloud information.
  3 in total

1.  Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro: two procoagulant activities are produced by peripheral blood mononuclear cells.

Authors:  B S Schwartz; G A Levy; L K Curtiss; D S Fair; T S Edgington
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

2.  Effects of exercise on the serum concentrations of FSH, LH, progesterone, and estradiol.

Authors:  A Bonen; W Y Ling; K P MacIntyre; R Neil; J C McGrail; A N Belcastro
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1979-09

Review 3.  An overview of the development of combined oral contraceptives containing estradiol: focus on estradiol valerate/dienogest.

Authors:  Franca Fruzzetti; Florence Trémollieres; Johannes Bitzer
Journal:  Gynecol Endocrinol       Date:  2012-04-02       Impact factor: 2.260

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.